By Professor Andrew Lloyd

Journal articles

Treloar C; McCredie L; Lloyd AR; Dolan K, 2015, 'Acquiring hepatitis C in prison: the social organisation of injecting risk', Harm Reduction Journal, 12, pp. 10, http://dx.doi.org/10.1186/s12954-015-0045-2

Sandler C; Hamilton B; Horsfield S; Bennett B; Casson S; Vollmer-Conna U; Tzarimas C; Lloyd A, 2015, 'Development of an optimised, multi-disciplinary intervention for chronic fatigue states', Physiotherapy, 101, pp. e1333 - e1334, http://dx.doi.org/10.1016/j.physio.2015.03.1262

Treloar C; Baldry E; Higgs P; Dietze P; Stoove M; Lloyd A, 2015, 'Going Tobacco Free in Australian Prisons - increasing tattoing harm?', International Journal of Prisoner Health, 11, http://dx.doi.org/10.1108/IJPH-04-2015-0011

Casson S; Sandler C; Horsfield S; Lloyd A; Barry B, 2015, 'Measuring activity pacing in patients with chronic fatigue syndrome', Physiotherapy, 101, pp. e202 - e203, http://dx.doi.org/10.1016/j.physio.2015.03.366

Maher L; White B; Dore G; Lloyd A; Rawlinson W, 2015, 'Opioid substitution treatment protects against hepatitis C virus acquisition in people who inject drugs: The HITS-c study', Drug and Alcohol Dependence, 146, pp. e191 - e191, http://dx.doi.org/10.1016/j.drugalcdep.2014.09.435

Bretaña N; Boelen L; Bull R; Teutsch S; White P; Lloyd A; Luciani F; Bretana N; Dolan K; Rawlinson W; Dore G; Maher L, 2015, 'Transmission of Hepatitis C Virus among Prisoners, Australia, 2005–2012.', Emerging Infectious Diseases, 21, pp. 765 - 774, http://dx.doi.org/10.3201/eid2105.141832

Grebely J; Dore GJ; Kim AY; Lloyd A; Shoukry NH; Prins M; Page K, 2014, 'Genetics of spontaneous clearance of hepatitis C virus infection: A complex topic with much to learn', Hepatology, 60, pp. 2127 - 2128, http://dx.doi.org/10.1002/hep.27163

Hajarizadeh B; Grady B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Geskus RB; Dore GJ; Grebely J; Lauer G; Shoukry NH; Hahn J; Shiboski S; Rice TM; Alavi M; Bouchard R; Aneja J; Teutsch S; White B; Wells B; Zang G; Matthews G; Marks P; Yeung B; Prince LE; Roy E; Bates A; Enriquez J; Chow S; McCredie L; Aitken C; Doyle J; Spelman T; Evans J, 2014, 'Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: The InC³ Study', Journal of Clinical Virology, 61, pp. 430 - 434, http://dx.doi.org/10.1016/j.jcv.2014.08.027

Luciani F; Bretaña NAR; Teutsch S; Amin J; Topp L; Dore GJ; Maher L; Dolan K; Lloyd AR; Bretana N, 2014, 'A prospective study of hepatitis C incidence in Australian prisoners', Addiction (Abingdon, England), 109, pp. 1695 - 1706, http://dx.doi.org/10.1111/add.12643

Luciani F; Bretaña NAR; Teutsch S; Amin J; Topp L; Dore GJ; Maher L; Dolan K; Lloyd AR; Bretana N, 2014, 'A prospective study of hepatitis C incidence in Australian prisoners', Addiction (Abingdon, England), 109, pp. 1695 - 1706, http://dx.doi.org/10.1111/add.12643

Hajarizadeh B; Grebely J; Applegate T; Matthews GV; Amin J; Petoumenos K; Hellard M; Rawlinson W; Lloyd A; Kaldor J; Dore GJ; Dolan K, 2014, 'Dynamics of HCV RNA Levels During Acute Hepatitis C Virus Infection', Journal of Medical Virology, 86, pp. 1722 - 1729, http://dx.doi.org/10.1002/jmv.24010

Raghuraman S; Lloyd AR; Zekry A, 2014, 'Obese visceral adipose tissue exhibits altered T cell trafficking patterns and confers a unique phenotype to tissue-resident T cells', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 29, pp. 23 - 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

White B; Dore GJ; Lloyd AR; Rawlinson WD; Maher L, 2014, 'Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: The HITS-c study', Medical Journal of Australia, 201, pp. 326 - 329, http://dx.doi.org/10.5694/mja13.00153

Boelen L; Teutsch S; Wilson DP; Dolan K; Dore GJ; Lloyd AR; Luciani F; Maher L, 2014, 'Per-event probability of hepatitis C infection during sharing of injecting equipment', PLoS ONE, 9, pp. e100749, http://dx.doi.org/10.1371/journal.pone.0100749

Yap L; Carruthers S; Thompson S; Cheng W; Jones J; Simpson P; Richards A; Thein HH; Haber P; Lloyd A; Butler T, 2014, 'A descriptive model of patient readiness, motivators, and hepatitis C treatment uptake among Australian prisoners.', PLoS One, 9, pp. 1 - 11, http://dx.doi.org/10.1371/journal.pone.0087564

Cvejic E; Lemon J; Hickie IB; Lloyd AR; Vollmer-Conna U, 2014, 'Neurocognitive disturbances associated with acute infectious mononucleosis, Ross River fever and Q fever: A preliminary investigation of inflammatory and genetic correlates', Brain, Behavior, and Immunity, 36, pp. 207 - 214, http://dx.doi.org/10.1016/j.bbi.2013.11.002

Martinez D; Palmer C; Simar D; Cameron B; Nguyen N; Aggarwal V; Lloyd A; Zekry A, 2014, 'Characterization of the cytokine milieu associated with the upregulation of IL-6 and suppressor of cytokine 3 in chronic hepatitis C treatment non-responders', Liver International, http://dx.doi.org/10.1111/liv.12473

Leung P; Bull R; Lloyd A; Luciani F, 2014, 'A bioinformatics pipeline for the analyses of viral escape dynamics and host immune responses during an infection', BioMed Research International, 2014, pp. 264519, http://dx.doi.org/10.1155/2014/264519

Bennett BK; Goldstein D; Chen M; Davenport TA; Vollmer-Conna U; Scott EM; Hickie IB; Lloyd AR, 2014, 'Characterization of fatigue states in medicine and psychiatry by structured interview', Psychosomatic Medicine, 76, pp. 379 - 388, http://dx.doi.org/10.1097/PSY.0000000000000061

Mina MM; Clark PJ; Beasley HM; Herawati L; Butler TG; Lloyd AR, 2014, 'Enhancing hepatitis C treatment in the custodial setting: A national roadmap', Medical Journal of Australia, 200, pp. 15 - 16, http://dx.doi.org/10.5694/mja13.10654

Leung P; Bull R; Lloyd A; Luciani F, 2014, 'Erratum: "A bioinformatics pipeline for the analyses of viral escape dynamics and host immune responses during an infection" (BioMed Research International)', BioMed Research International, 2014, http://dx.doi.org/10.1155/2014/680249

Hovey E; De Souza P; Marx G; Parente P; Rapke T; Hill A; Bonaventura A; Michele A; Craft P; Abdi E; Lloyd A, 2014, 'Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy', Supportive Care in Cancer, 22, pp. 1233 - 1242, http://dx.doi.org/10.1007/s00520-013-2076-0

Nguyen N; de Esch C; Cameron B; Kumar RK; Zekry A; Lloyd AR, 2014, 'Positioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus-infected liver correlates with local chemokine expression', Journal of Gastroenterology and Hepatology (Australia), 29, pp. 860 - 869, http://dx.doi.org/10.1111/jgh.12462

Nguyen N; Hampartzoumian T; Cameron B; Palmer C; O'Toole S; Post J; Zekry A; Lloyd A, 2014, 'Regulation of T cell recruitment and inflammation in the human immunodeficiency virus/hepatitis C virus coinfected liver', Journal of Gastroenterology and Hepatology (Australia), 29, pp. 1535 - 1543, http://dx.doi.org/10.1111/jgh.12543

Grebely J; Page K; Sacks-Davis R; van der Loeff MS; Rice TM; Bruneau J; Morris MD; Hajarizadeh B; Amin J; Cox AL; Kim AY; Mcgovern BH; Schinkel J; George J; Shoukry NH; Lauer GM; Maher L; Lloyd AR; Hellard M; Dore GJ; Prins M, 2014, 'The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection', Hepatology, 59, pp. 109 - 120, http://dx.doi.org/10.1002/hep.26639

Vollmer-Conna U; Piraino B; Lloyd A, 2014, '41. Immunogenetic and phenotypic explorations of the acute sickness response to common infections', Brain, Behavior, and Immunity, 40, pp. e12 - e13, http://dx.doi.org/10.1016/j.bbi.2014.06.061

Vollmer-Conna U; Cvejic E; Gunawardane U; Hadzi-Pavlovic D; Cameron B; Lloyd A, 2014, '42. Post-infective fatigue syndrome: Immunological and autonomic findings', Brain, Behavior, and Immunity, 40, pp. e13 - e13, http://dx.doi.org/10.1016/j.bbi.2014.06.062

Cvejic E; Lloyd A; Vollmer-Conna U, 2014, '43. Neurocognitive disturbances associated with acute infections: An investigation of inflammatory and genetic correlates', Brain, Behavior, and Immunity, 40, pp. e13 - e13, http://dx.doi.org/10.1016/j.bbi.2014.06.063

Hartfield M; Bull R; White PA; Lloyd A; Luciani F; Alizon S; Maher L, 2014, 'Evidence that hepatitis C virus genome partly controls infection outcome', Evolutionary Applications, 7, pp. 533 - 547, http://dx.doi.org/10.1111/eva.12151

Sugden PB; Cameron B; Luciani F; Lloyd AR; Maher L, 2014, 'Exploration of genetically determined resistance against hepatitis C infection in high-risk injecting drug users', Journal of Viral Hepatitis, 21, pp. e65 - e73, http://dx.doi.org/10.1111/jvh.12232

Sugden PB; Cameron B; Mina M; Lloyd AR; Luciani F; Maher L; Dolan K, 2014, 'Protection against hepatitis C infection via NK cells in highly-exposed uninfected injecting drug users', Journal of Hepatology, 61, pp. 738 - 745, http://dx.doi.org/10.1016/j.jhep.2014.05.013

Ahmadzai H; Cameron B; Chui J; Lloyd A; Wakefield D; Thomas PS, 2013, 'Measurement of neopterin, TGF-β1 and ACE in the exhaled breath condensate of patients with sarcoidosis', Journal of Breath Research, 7, http://dx.doi.org/10.1088/1752-7155/7/4/046003

Gunaratne P; Lloyd AR; Vollmer-Conna U, 2013, 'Mood disturbance after infection', Australian and New Zealand Journal of Psychiatry, 47, pp. 1152 - 1164, http://dx.doi.org/10.1177/0004867413503718

Feld JJ; Grebely J; Matthews GV; Applegate T; Hellard M; Sherker A; Cherepanov V; Petoumenos K; Yeung B; Kaldor JM; Lloyd AR; Dore GJ, 2013, 'Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infection', PLoS ONE, 8, pp. e80003, http://dx.doi.org/10.1371/journal.pone.0080003

Post JJ; Lloyd AR; Monkley D, 2013, 'Treatment outcomes for indigenous and non-indigenous inmates with hepatitis C in New South Wales prisons', Medical Journal of Australia, 199, pp. 464, http://dx.doi.org/10.5694/mja13.10925

Grebely J; Matthews GV; Lloyd AR; Dore GJ, 2013, 'Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: Feasibility and future requirements', Clinical Infectious Diseases, 57, pp. 1014 - 1020, http://dx.doi.org/10.1093/cid/cit377

Lloyd AR, 2013, 'Fatigue after infection: aetiology and pathophysiology', MICROBIOLOGY AUSTRALIA, 34, pp. 142 - 144, http://dx.doi.org/10.1071/MA13047

Post JJ; Arain A; Lloyd AR, 2013, 'Enhancing assessment and treatment of hepatitis c in the custodial setting', Clinical Infectious Diseases, 57, http://dx.doi.org/10.1093/cid/cit265

Lloyd AR, 2013, 'Apology', Journal of Internal Medicine, 273, pp. 628 - 628, http://dx.doi.org/10.1111/joim.12074

Grebely J; Feld JJ; Applegate T; Matthews GV; Hellard M; Sherker A; Petoumenos K; Zang G; Shaw I; Yeung B; George J; Teutsch S; Kaldor JM; Cherepanov V; Bruneau J; Shoukry NH; Lloyd AR; Dore GJ, 2013, 'Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection', Hepatology, 57, pp. 2124 - 2134, http://dx.doi.org/10.1002/hep.26263

Lloyd AR; Clegg J; Lange J; Stevenson A; Post JJ; Lloyd D; Rudge G; Boonwaat L; Forrest G; Douglas J; Monkley D, 2013, 'Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis c in the custodial setting', Clinical Infectious Diseases, 56, pp. 1078 - 1084, http://dx.doi.org/10.1093/cid/cis1202

Flynn JK; Dore GJ; Hellard M; Yeung B; Rawlinson WD; White PA; Kaldor JM; Lloyd AR; Ffrench RA; Dolan K, 2013, 'Maintenance of Th1 hepatitis C virus (HCV)-specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment', Journal of Gastroenterology and Hepatology (Australia), 28, pp. 1770 - 1781, http://dx.doi.org/10.1111/jgh.12265

Vollmer-Conna U; Piraino B; Lloyd AR, 2013, '26. Polymorphisms in both immune and behavioural genes affect mood as part of the acute sickness response to infection', Brain, Behavior, and Immunity, 32, pp. e8 - e8, http://dx.doi.org/10.1016/j.bbi.2013.07.038

Vollmer-Conna U; Gunawardane U; Patel V; Cvejic E; Lloyd AR, 2013, '39. Vagus nerve activity, a good night’s sleep, and recovery from acute infection', Brain, Behavior, and Immunity, 32, pp. e11 - e12, http://dx.doi.org/10.1016/j.bbi.2013.07.051

Cameron B; Galbraith S; Li H; Lloyd A; HITS investigators , 2013, 'Correlates and characteristics of hepatitis C virus-specific T-cell immunity in exposed uninfected high-risk prison inmates', Journal of Viral Hepatitis, 20, pp. e96 - e106, http://dx.doi.org/10.1111/jvh.12016

Post J; Arain A; Lloyd AR; Grebely J; Dore G, 2013, 'Enhancing Assessment and Treatment Hepatitis C in the Custodial Setting', Clinical Infectious Diseases, 57, pp. S70 - S74, http://dx.doi.org/10.1093/cid/cit264

Chang CC; Crane M; Zhou J; Mina M; Post JJ; Cameron BA; Lloyd AR; Jaworowski A; French MA; Lewin SR, 2013, 'HIV and co-infections', Immunological Reviews, 254, pp. 114 - 142, http://dx.doi.org/10.1111/imr.12063

Sugden PB; Pham TN; Ratnarajah S; Cameron B; Bull R; White PA; Michalak TI; Lloyd AR, 2013, 'Rare occurrence of occult hepatitis C virus in apparently uninfected injecting drug users: a two-centre, masked, case-control study', J Viral Hepat, 20, pp. 725 - 728, http://dx.doi.org/10.1111/jvh.12098

Goldstein D; Bennett BK; Webber K; Lloyd AR, 2012, 'Reply to A. Giacalone et al', Journal of Clinical Oncology, 30, pp. 4175 - 4176, http://dx.doi.org/10.1200/JCO.2012.45.6269

Mccredie L; Luciani F; Teutsch S; Amin J; Topp L; Dolan K; Lloyd A, 2012, 'BLOODY PRISONS: INCIDENCE OF RISK BEHAVIOURS AND HEPATITIS C VIRUS TRANSMISSION IN AN AUSTRALIAN PRISONER COHORT', DRUG AND ALCOHOL REVIEW, 31, pp. 57 - 57, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311236700175&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page